Indo National Board Meeting Date
Indo National's board meets on 12 November 2026 to approve unaudited half-year results. Insider trading window stays closed until 48 hours after results.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements with these filters
Indo National's board meets on 12 November 2026 to approve unaudited half-year results. Insider trading window stays closed until 48 hours after results.
Indo National invested Rs.0.25 Crore in 178 shares of Medcuore Medical Solutions, raising its stake to 63.46%. The acquisition targets growth in air monitoring and purifier business.
Indo National Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory disclosure of shareholding distribution.
Indo-National Ltd approved a Memorandum of Agreement to cease distribution arrangements with Radiohms Agencies, involving a net payment of ₹2.36 Crore for settling inter-se payables.
Indo National Limited has invested ₹3.91 Crore to acquire a further 0.30% stake in Axial Aero Private Limited, bringing its total holding to 7.97%.
Indo National acquired an additional 0.79% stake in Medcuore Medical Solutions for ₹0.50 Crore, taking its total shareholding in the subsidiary to 63.07%.
Indo National Ltd held its 53rd Annual General Meeting on September 28, 2026. Shareholders transacted ordinary and special business, including dividend declaration and auditor remuneration approval.
Indo-National Limited has scheduled its 53rd AGM and book closure from September 22 to 28, 2026. The record date for the dividend payment is September 21, 2026.
Indo National Ltd will invest ₹3.91 Crore in Axial Aero Pvt Ltd by subscribing to 35,249 Class C CCPS, increasing its stake to 7.97%.
Indo National Ltd invested Rs. 0.25 Crore to acquire an additional 0.41% stake in Medcuore Medical Solutions. This raises its total holding to 62.28%.
Indo National Limited has informed shareholders with unregistered email addresses about the availability of the FY 2025-26 Annual Report via a website link. This is a routine regulatory compliance filing.
Indo National Limited will hold its 53rd Annual General Meeting on September 28, 2026. The agenda includes adopting financial statements and declaring a Rs.3.75 per share dividend.
Indo National Limited submitted its 53rd Annual Report for FY 2025-26. The company convened its Annual General Meeting for September 28, 2026, via video conferencing.
Indo National Limited invested Rs. 0.50 Crore to acquire an additional 0.78% stake in Medcuore Medical Solutions Private Ltd. This increases its total shareholding to 61.87%.
Indo National Limited announced the resignation of Mr. Binu Sekhar from the position of Chief Sales Officer. The resignation is effective from September 1, 2026.
Indo National Ltd reported revenue from operations of ₹116.1 Cr (-2.8% YoY) and net profit of ₹2 Cr (+81.8% YoY) for Q1 FY27.